Interventional Clinical Trial Comparing Kerecis Omega3 Wound Versus SOC in Diabetic Foot Wounds (KereFish)
Interventional Multi-Center Post Market Randomized Controlled Open-Label Clinical Trial Comparing Kerecis Omega3 Wound Versus SOC in Hard to Heal Diabetic Foot Wounds
Sponsor: Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
Listed as NCT04537520, this NA trial focuses on Diabetes and Diabetic Foot Ulcer and remains completed. Sponsored by Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète, it has been updated 8 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2023 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2022 — Mar 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 3 earlier versions
-
Oct 2021 — Sep 2022 [monthly]
Recruiting NA
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Jul 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
- Clininfo S.A.
- Kerecis Ltd.
- RCTs
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Caen, France , Corbeil-Essonnes, France , Dijon, France , Le Creusot, France , Montpellier, France , Paris, France , Reims, France , Roubaix, France , Saint-Herblain, France , Strasbourg, France and 1 more location